Bernstein Initiates Coverage On Wendy’s with Outperform Rating, Announces Price Target of $25

While psychedelics reform is clearly gaining momentum, not only in the U.S. but notably in places like Australia and less so Canada. The fact is, all compounds remain currently Schedule I drugs (or equivalents) and thus federally illegal in many countries including the U.S.